Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

So far so good on 510(k) review in US

This article was originally published in RAJ Devices

Executive Summary

The general reaction to yesterday's release by the Food and Drug Administration of its keenly awaited road map for the regulatory tightening of the 510(k) premarket notification programme was one of mild relief, tinged with the suspicion that it's not all over yet.

You may also be interested in...



UK’s COVID-19 Track-And-Trace Confusion Persists

Surveillance and track-and-trace have emerged as the new focus of the UK’s COVID-19 control strategy, but a workable plan is yet to crystalize.

Germany Sets COVID-19 Testing Record And Prepares For Future Outbreaks

Having rapidly built a large-capacity COVID-19 testing strategy, Germany’s health system leaders are developing the capabilities to avert future outbreaks.

What Next For Medtech And Investors Post-Coronavirus?

If a post-COVID-19 economic recovery starts properly in September, as some have suggested, how swift would a return to normal be for medtech and life sciences businesses? It depends what the new normal looks like, suggests life sciences legal firm Goodwin. But in the regulatory arena, agencies are working hard to keep market access a priority during the ongoing public health emergency.

UsernamePublicRestriction

Register

CO234398

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel